| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00015 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 3.1e-05 | 1 |